PhoenixBio Co., Ltd. (TYO:6190)

Japan flag Japan · Delayed Price · Currency is JPY
391.00
-5.00 (-1.26%)
Jun 3, 2026, 3:30 PM JST
Market Cap1.59B +20.2%
Revenue (ttm)1.57B +1.6%
Net Income125.00M
EPS30.75
Shares Out 4.07M
PE Ratio12.71
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,400
Open394.00
Previous Close396.00
Day's Range391.00 - 396.00
52-Week Range368.00 - 724.00
Beta0.34
Analystsn/a
Price Targetn/a
Earnings DateMay 15, 2026

About PhoenixBio

PhoenixBio Co., Ltd. provides contract testing services for medical product development in Japan, the United States, and internationally. The company offers PXB-mouse, a chimeric mouse with a humanized liver used in drug development experiments; and PXB-cells, human hepatocytes for in vitro studies and experiments, as well as HBV study services. Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications. The company was founded in 2002 and is headquartered in Higashihiroshima... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 69
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 6190
Full Company Profile

Financial Performance

Financial Statements